- Primary immunization:
- Adults and >7 years: IM 0.5mL
- Repeat at 4-8 weeks after first dose and at 6-12 months after second dose
- Booster: IM 0.5mL every 10 years
- Adults and >7 years: IM 0.5mL
Injection: 5 Lf (flocculation units) per 5mL
None remarkable
Vaccine
Active immunization by toxoid-induced Ab production against Clostridium tetani exotoxin
- Malaise
- Rash
- Arthus reaction
- Nausea
- Hypotension
- Fever
- Guillain-Barre syndrome
- EEG disturbances
- Hypersensitivity to thimerosal
- Delay if acute/febrile illness
- Belimumab
Drug Status
| Availability | Prescription only |
| Pregnancy | Category C |
| Breastfeeding | Unknown |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Adsorbed Tetanus Vaccine | 40 IU | Injection | 20 D | Biological E. | Galaxy Pharma |
| Adsorbed Tetanus Vaccine | 40 IU | Injection | 10 D | Biological E. | Galaxy Pharma |
| Adsorbed Tetanus Toxoid Vaccine | 5Lf per 5mL | Injection | 1D, 10D | Serum Institute | Sai Pharma |
| Tetavax | FDC | Pre-filled Injection | 1D | Sanofi Pasteur | Surgipharm Ltd |